Marshall joined Royalty Pharma in 2013. Previously, Marshall was an executive director and the senior biotechnology analyst at Morgan Stanley. Marshall has a BA, Phi Beta Kappa, from Johns Hopkins University, a PhD from Columbia University and an MD from Columbia University.
